GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case Report

Gida Ayada; Sagit Zolotov; Raya Cohen; Tal Lavi; Muhammad Abdul-Ghani; Naim Shehadeh; Afif Nakhleh

doi:10.1089/dia.2024.0367

GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case Report

Gida Ayada
, Sagit Zolotov
, Raya Cohen
, Tal Lavi
, Muhammad Abdul-Ghani
, Naim Shehadeh
, Afif Nakhleh

Bar-Ilan University - Azrieli Faculty of Medicine

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English
Pages (from-to)	144-146
Number of pages	3
Journal	Diabetes Technology and Therapeutics
Volume	27
Issue number	2
Early online date	3 Oct 2024
DOIs	https://doi.org/10.1089/dia.2024.0367
State	Published - 1 Feb 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1089/dia.2024.0367

Cite this

@article{24c97368741440bfad0596e65d1a6bcb,

title = "GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case Report",

author = "Gida Ayada and Sagit Zolotov and Raya Cohen and Tal Lavi and Muhammad Abdul-Ghani and Naim Shehadeh and Afif Nakhleh",

year = "2025",

month = feb,

day = "1",

doi = "10.1089/dia.2024.0367",

language = "אנגלית",

volume = "27",

pages = "144--146",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "2",

}

TY - JOUR

T1 - GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes

T2 - A Case Report

AU - Ayada, Gida

AU - Zolotov, Sagit

AU - Cohen, Raya

AU - Lavi, Tal

AU - Abdul-Ghani, Muhammad

AU - Shehadeh, Naim

AU - Nakhleh, Afif

PY - 2025/2/1

Y1 - 2025/2/1

UR - https://www.scopus.com/pages/publications/85206336632

U2 - 10.1089/dia.2024.0367

DO - 10.1089/dia.2024.0367

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 39360432

AN - SCOPUS:85206336632

SN - 1520-9156

VL - 27

SP - 144

EP - 146

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

IS - 2

ER -

GLP-1 Receptor Agonist Therapy in Cystic Fibrosis-Related Diabetes: A Case Report

UN SDGs

Access to Document

Other files and links

Cite this